Noida-based drug firm Jubilant Life Sciences has received final approval from the US Food and Drug Administration (USFDA) for its generic Levetiracetam injection, used for the treatment of epilepsy, in the American market, the company saidâ€‹ in a filing. The formulation is similar to Belgium pharmaceutical major UCB's injection in the same strength, it added. 